Log in to save to my catalogue

Anti-ferroptosis exosomes engineered for targeting M2 microglia to improve neurological function in...

Anti-ferroptosis exosomes engineered for targeting M2 microglia to improve neurological function in...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_80452409c3c9490aac935f05f6ecc10e

Anti-ferroptosis exosomes engineered for targeting M2 microglia to improve neurological function in ischemic stroke

About this item

Full title

Anti-ferroptosis exosomes engineered for targeting M2 microglia to improve neurological function in ischemic stroke

Publisher

England: BioMed Central Ltd

Journal title

Journal of nanobiotechnology, 2024-05, Vol.22 (1), p.291-291, Article 291

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Stroke is a devastating disease affecting populations worldwide and is the primary cause of long-term disability. The inflammatory storm plays a crucial role in the progression of stroke. In the acute phase of ischemic stroke, there is a transient increase in anti-inflammatory M2 microglia followed by a rapid decline. Due to the abundant phospholip...

Alternative Titles

Full title

Anti-ferroptosis exosomes engineered for targeting M2 microglia to improve neurological function in ischemic stroke

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_80452409c3c9490aac935f05f6ecc10e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_80452409c3c9490aac935f05f6ecc10e

Other Identifiers

ISSN

1477-3155

E-ISSN

1477-3155

DOI

10.1186/s12951-024-02560-y

How to access this item